Advertisement

Overview of Diagnostic Terminology and Reporting

Chapter

Abstract

Lung cancer is the leading cause of cancer death in the United States. A number of new treatment options have impacted the need for accurate diagnosis and classification of primary pulmonary carcinomas. Not only must carcinomas be separated into small cell and non-small cell types, but adenocarcinoma must be separated from squamous cell carcinoma. Cytologic material obtained from pulmonary lesions displays a range of abnormalities varying from the clearly benign to the clearly malignant. The-six category system proposed by the Papanicolaou Society of Cytopathology categorizes the cytomorphologic features into clinically useful groups with estimated risks of malignancy.

Keywords

Lung cancer Categories Risk of malignancy Cytology Lung Diagnostic criteria 

References

  1. 1.
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.CrossRefGoogle Scholar
  2. 2.
    Yung RCW, Otell S, Illei P, et al. Improvement of cellularity on cell block preparations using the so-called tissue coagulum clot method during endobronchial ultrasound-guided transbronchial fine-needle aspiration. Cancer Cytopathol. 2012;120(3):185–95.CrossRefGoogle Scholar
  3. 3.
    Stoll LM, Yung RCW, Clark DP, Li QK. Cytology of endobronchial ultrasound-guided transbronchial needle aspiration versus conventional transbronchial needle aspiration. Cancer Cytopathol. 2010;118(5):278–86.CrossRefGoogle Scholar
  4. 4.
    Natu S, Hoffman J, Siddiqui M, Hobday C, Shrimankar J, Harrison R. The role of endobronchial ultrasound guided transbronchial needle aspiration cytology in the investigation of mediastinal lymphadenopathy and masses, the north tees experience. J Clin Pathol. 2010;63(5):445–51.CrossRefGoogle Scholar
  5. 5.
    Layfield LJ, Dodd L, Witt B. Malignancy risk for the categories: non-diagnostic, benign, atypical, suspicious, and malignant used in the categorization of endobronchial ultrasound guided-fine needle aspirates of pulmonary nodules. Diagn Cytopathol. 2015;43(11):892–6.CrossRefGoogle Scholar
  6. 6.
    Mehta HJ, Tanner NT, Silvestri G, et al. Outcome of patients with negative and unsatisfactory cytologic specimens obtained by endobronchial ultrasound-guided transbronchial fine-needle aspiration of mediastinal lymph nodes. Cancer Cytopathol. 2015;123(2):92–7.CrossRefGoogle Scholar
  7. 7.
    Lilo MT, Allison DB, Younes BK, et al. The critical role of EBUS-TBNA cytology in the staging of mediastinal lymph nodes in lung cancer patients: a correlation study with positron emission tomography findings. Cancer Cytopathol. 2017;125(9):717–25.CrossRefGoogle Scholar
  8. 8.
    Srinivasan R, Bhutani MS, Thosani N, et al. Clinical impact of EUS-FNA of mediastinal lymph nodes in patients with known or suspected lung cancer or mediastinal lymph nodes of unknown etiology. J Gastrointestinal Liver Dis. 2012;21(2):145–52.Google Scholar
  9. 9.
    Nayak A, Sugrue C, Koenig S, Wasserman PG, Hoda S, Morgenstern NJ. Endobronchial ultrasound-guided transbronchial needle aspirate (EBUS-TBNA): a proposal for on-site adequacy criteria. Diagn Cytopathol. 2012;40(2):128–37.CrossRefGoogle Scholar
  10. 10.
    Loo FL, Halligan AM, Port JL, Hoda RS. The emerging technique of electromagnetic navigation bronchoscopy-guided fine-needle aspiration of peripheral lung lesions: promising results in 50 lesions. Cancer Cytopathol. 2014;122(3):191–9.CrossRefGoogle Scholar
  11. 11.
    Odronic SI, Gildea TR, Chute DJ. Electromagnetic navigation bronchoscopy-guided fine needle aspiration for the diagnosis of lung lesions. Diagn Cytopathol. 2014;42(12):1045–50.CrossRefGoogle Scholar
  12. 12.
    Izumo T, Sasada S, Chavez C, Matsumoto Y, Hayama M, Tsuchida T. The diagnostic value of histology and cytology samples during endobronchial ultrasound with a guide sheath. Jpn J Clin Oncol. 2015;45(4):362–6.CrossRefGoogle Scholar
  13. 13.
    Collins BT, Chen AC, Wang JF, Bernadt CT, Sanati S. Improved laboratory resource utilization and patient care with the use of rapid on-site evaluation for endobronchial ultrasound fine-needle aspiration biopsy. Cancer Cytopathol. 2013;121(10):544–51.CrossRefGoogle Scholar
  14. 14.
    Karunamurthy A, Cai G, Dacic S, Khalbuss WE, Pantanowitz L, Monaco SE. Evaluation of endobronchial ultrasound-guided fine-needle aspirations (EBUS-FNA): correlation with adequacy and histologic follow-up. Cancer Cytopathol. 2014;122(1):23–32.CrossRefGoogle Scholar
  15. 15.
    Kuo C, Lin S, Lee K, et al. Endobronchial ultrasound-guided transbronchial biopsy and brushing: a comparative evaluation for the diagnosis of peripheral pulmonary lesions. Eur J Cardio-Thoracic Surg. 2013;45(5):894–8.CrossRefGoogle Scholar
  16. 16.
    KaKodKar UC, Vadala R, Mandrekar S. Utility of cell-block of bronchial washings in diagnosis of lung cancer–a comparative analysis with conventional smear cytology. J Clin Diagn Res. 2016;10(4):OC25.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Sun W, Song K, Zervos M, et al. The diagnostic value of endobronchial ultrasound-guided needle biopsy in lung cancer and mediastinal adenopathy. Diagn Cytopathol. 2010;38(5):337–42.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Alsharif M, Andrade RS, Groth SS, Stelow EB, Pambuccian SE. Endobronchial ultrasound–guided transbronchial fine-needle aspiration: the university of Minnesota experience, with emphasis on usefulness, adequacy assessment, and diagnostic difficulties. Am J Clin Pathol. 2008;130(3):434–43.CrossRefGoogle Scholar
  19. 19.
    Lee HS, Kwon SY, Kim DK, et al. Bronchial washing yield before and after forceps biopsy in patients with endoscopically visible lung cancers. Respirology. 2007;12(2):277–82.CrossRefGoogle Scholar
  20. 20.
    Griffin JP, Zaman MK, Niell HB, Tolley EA, Cole FH Jr, Weiman DS. Diagnosis of lung cancer: a bronchoscopist’s perspective. J Bronchology Interv Pulmonol. 2012;19(1):12–8.CrossRefGoogle Scholar
  21. 21.
    Schramm M, Wrobel C, Born I, et al. Equivocal cytology in lung cancer diagnosis. Cancer Cytopathol. 2011;119(3):177–92.CrossRefGoogle Scholar
  22. 22.
    Dobler CC, Crawford ABH. Bronchoscopic diagnosis of endoscopically visible lung malignancies: should cytological examinations be carried out routinely? Intern Med J. 2009;39(12):806–11.CrossRefGoogle Scholar
  23. 23.
    Voss JS, Kipp BR, Halling KC, et al. Fluorescence in situ hybridization testing algorithm improves lung cancer detection in bronchial brushing specimens. Am J Respir Crit Care Med. 2010;181(5):478–85.CrossRefGoogle Scholar
  24. 24.
    Itoguchi N, Nakagawa T, Murata Y, et al. Immunocytochemical staining for stratifin and OCIAD2 in bronchial washing specimens increases sensitivity for diagnosis of lung cancer. Cytopathology. 2015;26(6):354–61.CrossRefGoogle Scholar
  25. 25.
    Layfield LJ, Baloch Z, Elsheikh T, et al. Standardized terminology and nomenclature for respiratory cytology: the Papanicolaou Society of Cytopathology guidelines. Diagn Cytopathol. 2016;44(5):399–409.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Pathology and Laboratory MedicineHospital of the University of PennsylvaniaPhiladelphiaUSA
  2. 2.Department of Pathology and Laboratory MedicineTemple University HospitalPhiladelphiaUSA
  3. 3.Department of Pathology and Anatomical SciencesUniversity of MissouriColumbiaUSA

Personalised recommendations